Short Title:
Non-pharm Motion Sickness Mitigation – Lab
Responsible HRP Element:
Human Health Countermeasures
Funding Status:
Active - Currently funded and in progress
|
Procurement Mechanism(s):
|
|
Aims:
SA1: Evaluate the effect of timing on the administration of a nonpharmaceutical treatment (galvanic vestibular reduction [GVR]) for motion sickness.
SA2: Evaluate the effect of GVR amplitude on functional fitness task performance.
Other Resources
| Other Resources Needed?
|
Yes
|
Category:
Countermeasure
Subcategory:
Protocol
Description:
This task will deliver a non-pharmaceutical countermeasure approach using galvanic vestibular reduction (GVR) that can be customized to mitigate G-transitional induced motion sickness while optimizing sensorimotor and cognitive performance.
Internal Customers:
None
External Customers:
None